BIOCERAM
ActiveBIOCERAM has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €638k and a net result of €132k. Equity is growing by ~20.6% per year across the filed fiscal years. Its solvency ranks better than 70% of 117 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
93
/ 100
Excellent▼ -7 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Stability100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €60k at 30 days acceptable
Liquidity ample (current ratio 2.03 against 3.13 in 2024), and 31.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 32
Relative position
BE, all sectors
reference
Sector 32
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
68.2%
Return on assets
14.1%
Age of the figures
11 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 31-03-2026, 30 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
30 d early
2024
34 d early
2023
4 d early
2022
17 d early
2021
30 d early
2020
1 d early
2019
2 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
13-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€132k▼ 53.1%
2024 · €282k
2018: €44k
2019: €156k
2020: €10k
2021: €11k
2022: €187
2023: €-62k
2024: €282k
2018 → 2025
Working capital
€305k▼ 30.0%
2024 · €435k
2018: €63k
2019: €155k
2020: €150k
2021: €128k
2022: €141k
2023: €151k
2024: €435k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€287k-€287k=€225k▼ 21.7%€506k▲ 125%€638k▲ 26.1%
Operating result€23k-€3k▼ 87.7%€41k▲ 1,340%€393k▲ 852%€193k▼ 51.0%
Net result€11k-€187▼ 98.2%€-62k€282k€132k▼ 53.1%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 51% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €936k
Fixed assets
€334k▲ 335%
Current assets
€602k▼ 5.9%
Equity and liabilities €936k
Equity
€638k▲ 26.1%
Debt
€297k▲ 41.5%
The debt ratio rises from 29.3% to 31.8%: debt grows faster than equity.
Key figures and ratios
EBITDA
€223k▼
2024 · €418k
Cash flow
€162k▼
2024 · €307k
Solvency
68.2%▼
2024 · 70.7%
Current ratio
2.03▼
2024 · 3.13
Quick ratio
1.95▼
2024 · 3.00
Debt / equity
0.47▲
2024 · 0.41
ROE
20.7%▼
2024 · 55.6%
ROA
14.1%▼
2024 · 39.3%
Interest coverage
77.83▼
2024 · 351.73
Debt
€297k▲
2024 · €210k
Debt ≤ 1 year
€297k▲
2024 · €204k
Income taxes
€61k▼
2024 · €112k
Staff costs
€605k▲
2024 · €545k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€716k€936k▲
Fixed assets21/28€77k€334k▲
Tangible fixed assets22/27€77k€334k▲
Plant, machinery and equipment23€36k€46k▲
Furniture and vehicles24€7k€5k▼
Other tangible fixed assets26€34k€282k▲
Current assets29/58€639k€602k▼
Stocks and contracts in progress3€27k€24k▼
Stocks30/36€27k€24k▼
Amounts receivable within one year40/41€221k€124k▼
Trade receivables40€210k€112k▼
Other amounts receivable41€11k€12k▲
Cash at bank and in hand54/58€386k€449k▲
Deferred charges and accrued income490/1€4k€5k▲
Equity and liabilities
Total equity and liabilities10/49€716k€936k▲
Equity10/15€506k€638k▲
Contributions10/11€19k€19k=
Reserves13€67k€198k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Tax-exempt reserves132€65k€65k=
Distributable reserves133-€131k
Profit (loss) carried forward14€421k€422k▲
Amounts payable17/49€210k€297k▲
Amounts payable after more than one year17€6k-
Financial debts170/4€6k-
Amounts payable within one year42/48€204k€297k▲
Current portion of amounts payable after more than one year42€9k€27k▲
Trade debts44€51k€161k▲
Suppliers440/4€51k€161k▲
Taxes, remuneration and social security45€145k€109k▼
Taxes450/3€107k€59k▼
Remuneration and social security454/9€38k€50k▲
Income statement
Code20242025
Remuneration, social security and pensions62€545k€605k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€25k€30k▲
Other operating charges640/8€384€387▲
Gross operating margin9900€964k€829k▼
Operating profit (loss)9901€393k€193k▼
Financial income75/76B€1k€3k▲
Recurring financial income75€1k€3k▲
Financial charges65/66B€1k€3k▲
Recurring financial charges65€1k€3k▲
Profit (loss) for the period before taxes9903€393k€193k▼
Income taxes67/77€112k€61k▼
Profit (loss) for the period9904€282k€132k▼
Profit (loss) for the period to be appropriated9905€282k€132k▼
Appropriation of the result
Profit (loss) to be appropriated9906€421k€553k▲
Profit (loss) brought forward from the previous period14P€139k€421k▲
Transfer to equity691/2-€131k
To other reserves6921-€131k
Social balance
Average headcount (FTE)9087-9.0
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-03
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
27-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-09
Financial
Back to profitnet €282k
Net result €282k after one loss-making year.
30-09
Financial
Equity above €500kEq €506k ▲125%
Equity rises from €225k to €506k.
26-04
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-09
Financial
Weakest financial yearnet €-62k ▼33068%
Net result drops to €-62k, the lowest in the series; recovery starts the following year.
13-04
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-03
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
29-04
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
28-04
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
30-09
Financial
Equity above €200kEq €267k ▲141%
2 profitable years in a row build equity to €267k.
29-03
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
04-04
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
21-03
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Overijse · 1 establishment unit since 2004
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Terhulpensesteenweg 4223090 OverijseGround area
1,561 m²
2 parcels, Brussels, Flanders. Linked by address, not a title deed.
1 establishment unit
Bioceram
since 20042.143.233.014
2 parcels
Flanders
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23543I0301/00F002 | Flanders | 1,461 m² | - | - |
| 21673D0150/00F049 | Brussels | 100 m² | - | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Orthopedica - Algemeen centrum technische voetorthopedie
BE 0465.277.227
Waasmunster · Eq €640k
PRO SCAN
BE 0899.775.364
Zonhoven · Eq €640k
Orthopedie Vandeperre
BE 0420.122.440
Wommelgem · Eq €635k
INTERDENTAL
BE 0432.750.058
Mol · Eq €626k
ORTHO-FESKENS
BE 0434.253.855
Zoersel · Eq €658k
Of 1,245 companies in sector 32500 we hold annual accounts for 692. 476 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded27-10-2004
Fiscal year end30-09
Activities, NACEBEL
32500Manufacture of medical and dental instruments and supplies
33103
Sources
Crossroads Bank for EnterprisesNational Bank · 21 filingsAddress and cadastre registers
Data from official sources, last processed on 12-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:0477/595431